Breast Cancer

Drug approval for breast cancer

The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer…
notes note pink important

Take Note – September 2008

Johnson & Johnson’s Campaign for Nursing’s Future     In 2002, Johnson & Johnson launched the Campaign for Nursing’s Future to enhance the image of nursing,…
cpr family friend note

Take Note – February 2007

Low-carb diets don’t affect cardiac risk Although diets low in carbohydrates and high in fats and proteins have been popular for the last few…
flu shot kids note

Take Note – October 2006

CDC recommends annual flu shots for children ages 2 to 4 For the first time, the Centers for Disease Control and Prevention (CDC) is…

Drug approval for breast cancer

The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced…
notes note pink important

Take Note – September 2008

Johnson & Johnson’s Campaign for Nursing’s Future     In 2002, Johnson & Johnson launched the Campaign for Nursing’s Future to enhance the image…
cpr family friend note

Take Note – February 2007

Low-carb diets don’t affect cardiac risk Although diets low in carbohydrates and high in fats and proteins have been popular for the…
flu shot kids note

Take Note – October 2006

CDC recommends annual flu shots for children ages 2 to 4 For the first time, the Centers for Disease Control and Prevention…
cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following patients is at the highest risk for developing autonomic dysreflexia (AD)?